Center Trials & Treatment

Center Trials & Treatment is a clinical-stage biotechnology company specializing in neuro-oncology and innovative drug delivery systems. The company focuses on developing intranasal therapies for brain tumors, such as glioblastoma and malignant glioma, designed to bypass the blood-brain barrier for improved therapeutic efficacy. Its pipeline includes proprietary nasal spray formulations like NST-4G (a combination of axitinib, sunitinib, and pazopanib) and intranasal temozolomide, alongside clinical programs evaluating targeted therapies like afatinib and talazoparib. Additionally, the company manages expanded access programs for immunotherapies and has conducted research into infectious diseases, including COVID-19.